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1. Introduction 
Bones and tendons are obtained from donors who have been pronounced brain dead after a 
rigid and extensive screening process. The tissues obtained are sent to a Tissue Bank and 
submitted to processing steps, packaging and cryopreservation at -80◦C. It is vital to 
maintain sterility and integrity, so that no tissue is discarded.These precautions also extend 
to the packaging, which should promote containment and protection. Although minimum 
technical criteria have already been defined for the food industry, this has still not been 
regularized in Brazil. We emphasize, therefore, the need to study this subject, focusing on 
maintaining the quality of the musculoskeletal tissues produced by tissue banks. All 
procedures developed byTissue Banks currently present in the country have rigid control 
over the quality and the traceability of tissues made available, based on international 
standards (EATB, 2004; AATB, 2007) on the legislation (BRASIL, 1997-2006) and in 
conformity with Good Manufacturing Practices - GMP. 
2. Cryopreservation of musculoskeletal tissues 
In the cryopreservation room, the tissues are stored according to their status in the process. 
Thus, there are designated areas for tissues under analysis or in quarantine (where they 
remain for around 60 days before the result of all the exams) and for those that have been 
liberated for use. both areas are equipped with ultra-low temperature freezers, with 
temperatures ranging from minus 80 to minus 100 degrees Celsius. 
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The room is also equipped with an air conditioning system, its own energy generator, and 
carbon gas backup as protection against defrosting, as well as a rigorous temperature 
monitoring system that generates 24-hour printed temperature recordings, and a satellite 
alarm system, which ensures adequate maintenance of the temperature and early detection 
of any flaws.  
Depending on the results of the analyses, the tissues are transferred to the room designated 
for materials liberated for use. The maximum cryopreservation period is 5 years for bone 
tissue and 2 years for soft or tendinous tissues. 
It is vital to maintain sterility and integrity, in order to avoid disposal of any material. 
This is the purpose of packaging, which is aimed at containment and protection. In Brazil, 
there are no specific regulations for packaging of sterile, cryopreserved tissues for 
transplants, and in this chapter, we present our experience in the definition and validation 
of a type of packaging used for this purpose. Our proposal is to characterize a coextruded 
plastic film structure used for packaging of musculoskeletal tissues at low temperatures, 
in regard to the aspects sterility, cytotoxicity, migration, mechanical resistance and 
oxygen permeability.  
 
 
Fig. 1. Cryopreservation of tissues at -80 ◦C in drawers, separated by batches. 
3. Validation of packaging for use in tissue cryopreservation. 
3.1 Description of our sample 
A roll of transparent, unprinted seven layers, coextruded plastic:  
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Layer 01: LLDPE – 1-octene comonomer Linear Low-Density Polyethylene 
Layer 02: LLDPE – 1-octene comonomer Linear Low-Density Polyethylene and 1-octene 
comonomer Linear Low-Density Polyethylene modified with anhydride maleic 
Layer 03: PA – hexamethylenediamine, adipic acid e caprolactam copolyamide 
Layer 04: LLDPE – 1-octene comonomer Linear Low-Density Polyethylene and 1-octene 
comonomer Linear Low-Density Polyethylene modified with anhydride maleic 
Layer 05: PA – hexamethylenediamine, adipic acid e caprolactamcopolyamide 
Layer 06: LLDPE – 1-octene comonomer Linear Low-Density Polyethylene and 1-octene 
comonomer Linear Low-Density Polyethylene modified with anhydride maleic 
Layer  07: LLDPE – 1-octene comonomer Linear Low-Density Polyethylene 
In relation to the physicomechanical and barrier properties characteristics, we investigated 
the alterations that occurred in the packages after 30, 60, 90, 120, and 150 days of 
cryopreservation at -80◦C.  For the cytotoxicity and sterility analysis, two groups (before and 
after sterilization by ethylene oxide) were analysed. 
3.2 Physicomechanical and barrier properties tests 
A) Characterization of coex film in relation to its thickness and water vapor transmission 
rate (WVTR) 
The thickness of each layer of plastic material in the film sample was determined through 
images captured by a Metaval inverted microscope operating at a magnification of 200x, 
using the image analysis system Axio Vision (Zeiss®). The cross-section of the sample was 
obtained using a Leica microtome, model RM2245, with section thickness set to 40 μm. To 
facilitate visualization of the barrier layer, 2% iodine solution was used as a contrasting 
agent. Five cross-section samples of the material were obtained; five measurements were 
performed for each sample, totalling 25 thickness measurements. The test was carried out 
at a temperature of around 23°C, after packaging of the sample in a controlled 
environment at 23°C ± 2°C and (50 ± 3)% relative humidity for a minimum period of 48 
hours. 
The water vapor transmission rate was determined using a MOCON PERMATRAN-W 3/31 
device, following the procedure described in regulation ASTM F1249-06 - Standard test 
methods for water vapor transmission rate through plastic film and sheeting using a 
modulated infrared sensor. In this test, the water vapor that passes through the film is 
carried to the infrared sensor by ultra-dry nitrogen flow. The sensor measures the fraction of 
energy absorbed by the water vapor, and emits an electrical signal with amplitude 
proportional to the concentration of water vapor. The range of this signal is compared with 
that of the signal produced by the water vapor that passes through a calibration film with a 
known water vapour transmission rate. The effective permeation area of each sample was 
50cm2. The assay was performed at 38oC/100%RH and in this condition, the calibration 
standard showed water vapour transmission rate of 4.54g water.m-2.day-1. The water vapor 
transmission rate of the sample was corrected for the condition 38oC/90%RH, multiplying 
the results by a factor of 0.9. 
The total thickness of each layer of coextruded film is shown in Table 1. Figure 10 shows an 
example of a cross-section image of the sample obtained for the assay. 
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Determinations 
Thickness (µm) 
Mean Variation Interval Coefficient of variation (%) 
Total 91.1 90.0 – 92.9 0.9 
LLDPE (A) 27.3 26.2 – 28.5 2.4 
LLDPE blend (B) 7.6 7.0 – 8.0 3.8 
PA (C) 5.6 5.1 – 5.9 4.8 
LLDPE blend (D) 6.8 5.3 – 7.8 11 
PA (C) 5.6 5.0 – 6.0 5.6 
LLDPE blend (F) 7.7 7.1 – 8.6 5.9 
LLDPE (G) 31.0 30.1 – 32.1 1.9 
Values for 25 measurements 
A-G: Text for visualization in Figure 10 
Table 1. Total thickness of each layer of sample of coextruded plastic film. 
Thus, by optical microscopy, it was observed that it is a coextruded material with seven 
layers, with two intermediate layers of PA of approximately 6µm each. The other LLDPE 
layers totalled 80µm. 
 
 
 
 
 
 
 
Fig. 2. Example of cross-section image of the sample obtained with the microscope operating 
at a magnification of 200x. 
The characterization of the film in relation to water vapor transmission rate is shown in 
Table 2. 
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Sample 
WVTR (g water . m-2.day-1) 
Mean VI CV (%) 
Coextruded film 
LLDPE / LLDPE / PA / LLDPE / PA / 
LLDPE / LLDPE 
3.30 3.2 – 3.4 4.4 
Values relate to four measurements 
VI – variation interval; CV – coefficient of variation 
Table 2. Water vapor transmission rate (WVTR) of the coextruded plastic film at 
38C/90%RH – Permatran-W 3/31 method. 
The WVTR depends on the thickness of the LLDPE layers of the coex film (80µm).  
B) Penetration resistance 
The penetration resistance of the coextruded film was determined based on Standard ASTM 
F 1306-90 (2008) e1 - Standard test method for slow rate penetration resistance of flexible 
barrier films and laminates, on an Instron 5500R universal testing machine, using load cells 
of 100 N. The speed of penetration, performed with a spherical-tipped metal probe with 
diameter of approximately 3.2 mm, was 25 mm/min. The penetration was performed from 
the inner surface to the outer surface of the material. The test was conducted in an 
environment of 23°C ± 2°C and (50 ± 3)% relative humidity, after leaving the packaged 
samples for a minimum period of 48 hours in this environment. 
The evaluation of penetration resistance was carried out on samples in their original or non-
frozen condition (0) and 30, 60, 120 and 150 days after freezing at  -80 ◦C. The data are 
shown in Table 3 and Figure 3. 
 
Penetration  
resistance 
Evaluation periods (days) 
0 30 60 90 120 150 
Force at break 
(N) 
Mean 12.1 ab 12.6 bc 12.9 c 12.6 bc 11.1 d 11.8 a 
VI 11.5–12.7 11.8– 13.5 11.9– 14.2 11.2– 14.1 9.4 – 12.3 10.9– 12.4 
CV (%) 3.1 3.6 4.7 6.9 9.1 3.7 
Deformation 
at break (mm) 
Mean 9.4 a 11.0 b 10.0 c 9.8 c 8.3 d 9.0 e 
VI 9.2 – 9.8 10.7– 11.4 9.5 – 10.5 8.9 – 10.6 7.4 – 9.1 8.2 – 9.5 
CV (%) 2.3 2.3 2.6 5.2 5.5 3.7 
Energy at 
break (mJ) 
Mean 70 ad 76 b 78 b 73 ab 62 c 69 d 
VI 64 – 74 70 – 84 72 – 85 64 – 86 52 – 73 62 – 73 
CV (%) 4.6 5.5 5.4 8.6 11 5.6 
Values relate to 10 measurements: 1 N = 0.102 kgf 
VI/CV: Variation interval/Coefficient of variation 
a,b,c,d: for an analyzed property, mean values on the same line accompanied by the same superscript 
letter did not show any difference between them in the least significant difference (LSD) test, at a level 
of error of 5%. 
Table 3. Penetration resistance of the sample during storage at -80°C. 
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Fig. 3. Penetration resistance of the sample during the period of storage at -80°C ( days). 
The results shown in Table 3 and Figure 3 demonstrate that the process of sterilization and 
packaging of human bone, and storage for 150 days at -80°C, did not alter the penetration 
properties of the coextruded film. Variations were observed in the results of the three 
properties evaluated, including statistical differences in some periods/properties, but as 
these variations were small, without any clearly-defined trend, no alteration is expected in 
penetration resistance of the film during packaging and storage of human tissue for a period 
of 150 days at -80 °C. 
C) Seal strength 
The seal strength of the packaging was determined according to ASTM F 88/F 88M-09 - 
Standard test method for seal strength of flexible barrier materials. Samples of 25.4 mm in 
width were submitted to tensile test in a 5500R Instron universal testing machine, operating 
with load cells of 50N and 100N, at a speed of 300mm/min. The distance between the fixing 
clamps and the sample was 25mm. The test was conducted in an environment of 23 °C ± 2 
°C and (50 ± 3)% relative humidity, after leaving the pre-prepared, packaged samples in this 
same environment for at least 48 hours. 
The strength of the side seal is different from that of the top seal, because the top seal of the 
packaging was made after the bone tissue packaging process, while the side seals were 
made by the package manufacturer. 
Despite this, there was no statistical difference between the results obtained for both seals. 
Thus, the sterilization and packaging process of human tissue, and storage for 150 days at -
80°C did not alter the seal strength. 
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Maximum seal strength 
(kgf/25.4 mm) 
Evaluation periods (days) 
0 30 60 90 120 150 
Side seal 
Mean 3.60 ab 3.65 b 3.60 ab 3.73 b 3.73 b 3.44 a 
VI 
3.36 – 
3.95
3.41 – 
3.83
3.38 – 
3.80
3.34 – 
3.97
3.43 – 
3.96
3.12 – 
3.78 
CV (%) 4.4 4.0 4.4 5.7 4.5 7.0 
Top seal 
Mean - 4.69 a 4.75 a 5.07 a 5.09 a 4.84 a 
VI - 3.65 – 
5.20
3.20 – 
5.85
4.31 – 
5.95
4.68 – 
5.54
4.48 – 
5.44 
CV (%) - 9.6 15 9.6 5.1 6.6 
Values relate to ten determinations: 1 kgf/25.4 mm = 386.1 N/m 
VI/CV: Variation interval/Coefficient of variation 
a,b: for a seal type, mean values on the same line accompanied by the same superscript letter did not 
show any difference between them in the least significant difference (LSD) test, at a level of error of 5%. 
Table 4. Seal strength during storage at -80°C. 
 
Fig. 4. Maximum seal strength during the period of storage at -80°C ( days).  
D) Oxygen transmission rate 
The oxygen transmission rate at humid was determined by the coulometric method, 
according to the procedure described in ASTM F 1927 - Standard test method for 
determination of oxygen gas transmission rate, permeability and permeance at controlled 
relative humidity through barrier materials using a coulometric detector, on MOCON 
OXTRAN device, model 2/20, operating with pure oxygen as permanent gas. The tests were 
carried out at 23oC to 75%RH, with the samples packaged for 88 to 112 hours in a 
temperature-controlled room at 25ºC and 75%RH. The effective area of permeation of each 
sample was 50cm2. The result obtained was corrected for 1 atm of partial pressure gradient 
of oxygen. 
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O2TR 
mL (STP).m-
2.day-1 at 
23°C/75%RH 
Evaluation periods (days) 
0 30 60 90 120 150 
Mean 69.75 a 75.95 a 74.97 a 82.57 a 76.98 a 113.67 b 
VI 
68.63–
70.87 
71.77-
80.14 
74.48-
75.46 
79.34-
85.80 
73.83-
80.13 
105.05-
122.29 
CV (%) 2.3 7.8 0.9 5.5 5.8 10.7 
values relate to two determinations 
VI – variation interval; CV – coefficient of variation 
a,b: for a seal type, mean values on the same line accompanied by the same superscript letter did not 
show any difference between them in the least significant difference (LSD) test, at a level of error of 5%. 
Table 5. Oxygen transmission rates (O2TR) during storage at -80°C.   
 
Fig. 5. Oxygen transmission rates (O2TR) during storage at -80°C. 
The results of the oxygen permeability rates shown in Table 5 and Figure 5 indicate a mean 
increase of 10% in permeability after the process of sterilization, vacuum packaging of the 
bone, and storage at -80°C, which was observed after 30 days of storage. This tendency to 
increase, probably due to humidification of the PA, led to a small loss of barrier which was 
maintained throughout the storage period of 120 days.  Meanwhile, in the analysis of 
samples from 30 days of storage at -80°C, a high oxygen transmission rate of was observed, 
which was not expected, and as we did not have any more stored samples, it was not 
possible to re-evaluate this result. This higher O2TR may be the result of some variation in 
thickness of the PA in the samples evaluated in this period. In any case, the level of oxygen 
transmission rate of the film did not lead to loss of vacuum in the samples stored in the 
Tissue Bank for 150 days at -80°C. 
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E) Overall Migration 
The evaluations of overall migration were performed according to Resolution 51 of 26 
November 2010 published by Agência Nacional de Vigilância Sanitária do Ministério da Saúde 
(National Agency of Sanitary Surveillance of Health Ministry) in Diário Oficial da União 
(official journal of the Brazilian Government) on 30 November 2010. This Resolution 
internalizes Mercosul Technical Regulation GMC 32/10. 
The methodology to quantify the overall migration was according to the method of the 
European Standard EN 1186-1: materials and articles in contact with foodstuffs. Plastics. 
Part 1: guide to the selection of conditions and test methods for overall migration, EN 1186-
3: Materials and articles in contact with foodstuffs. Plastics. Test methods for overall 
migration into aqueous food simulants by total immersion and EN 1186-14: materials and 
articles in contact with foodstuffs. Plastics. Part 1: Part 14: test methods for "substitute tests" 
for overall migration from plastics intended to come into contact with fatty foodstuffs using 
test media isooctane and 95% ethanol and consists of the sample contact with extraction 
solutions in certain periods and temperatures that simulate their actual condition of use. The 
residues of overall migration were determined by the weight difference after the contact and 
evaporation of the solutions through an analytical scale with 0.01mg of accuracy. The 
sample was evaluated under the contact conditions shown in Table 6. 
 
Model Solution Contact condition 
Ultra purified water 40oC/10 days
Acetic acid solution in Ultra purified 
water at 3% (w/v)
40oC/10 days 
Isooctane 40oC/10 days
Table 6. Conditions of time and temperature used in the overall migration. 
The results of the overall migration tests performed on the transparent coextruded plastic film, 
obtained using the model solutions and the specific contact conditions are shown in Table 7. 
 
Model 
Solution/Contact 
Condition 
Maximum 
limit of 
overall 
migration
Sample Mean 
Standard 
Deviation 
Variation 
interval 
Ultra purified
water/ 
40oC/10 days
8.0 
Before EtO  0.72 0.21  0.50(2) - 1.00 
After EtO  0.51 0.02  0.50(2) - 0.55 
3% Acetic acid 
solution (w/v)/ 
40oC/10 days
8.0 
Before EtO  0.54 0.09  0.50(2) – 0.67 
After EtO 0.92 0.19 0.72 – 1.12 
Isooctane/ 
20oC/48 hours 
8.0 
Before EtO  1.21 0.64  0.50(2) – 1.85 
After EtO  1.50 0.72  0.50(2) – 2.05 
(1) Result of four determinations. 
(2) Limit of quantification of the method in the analytical conditions used. 
(3) Not applicable. 
Table 7. Residues of overall migration obtained for the transparent coextruded plastic film, 
before and after the application of EtO, in mg/dm2 (1). 
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The maximum limit of overall migration provided by Resolution nº105/99 is of 8mg of 
residue per dm2 of contact plastic material, with an analytical tolerance of 10%. Therefore 
8.8mg/dm2 is the maximum tolerable value. 
The overall migration values found in the samples analyzed, in the analytical conditions 
used, were below the established limit. There was no statistical significance with 
sterilization with ethylene oxide (EtO). 
E 1.) Physicochemical tests – According to USP 33 
The physicochemical tests were conducted based in the methodology describe in the 
Chapter <661> Containers – Plastics - Physicochemical Tests of the United States 
Pharmacopeia (USP 33). 
In accordance to the United States Pharmacopeia, physicochemical tests are designed to 
determine physical and chemical properties of plastic materials. The extracts methodology 
consists of the sample contact with a extraction solution (deionized water) at 70ºC during 24 
hours, maintaining the ratio area / volume of 120 cm2 total surface area of plastic material 
for each 20 mL of extraction solution. 
The analyzed sample was received in the form of the film cut into strips with dimensions of 
5.0 cm long, 0.3 cm wide and thickness less than 0.1 cm. In this case, the thickness of the 
material to determine the total area was not considered and was maintained the ratio of 120 
cm2 for each 20 mL of extraction solution. Water was used as extraction solution. 
After the contact, the extraction solution and blank reagent were analyzed by the following 
tests:  
Buffering Capacity: Titrate 20 mL of the extraction solution potentiometrically to a pH of 
7.0, using 0.01 N sodium hydroxide. Treat a 20.0 mL portion of the blank reagent similarly. 
The difference between the two volumes can not be greater than 10.0 mL. 
Nonvolatile Residue: 50 mL of the extraction solution were evaporated on a hot plate, after 
the residue was dried at 105ºC for 1 hour on a oven and finally the nonvolatile residue was 
weighted through an analytical balance with 0.01mg of accuracy. Treat a 50.0 mL portion of 
the blank reagent similarly. The difference between the two volumes can not be greater than 
15.0 mg. 
Residue on Ignition: in the residues obtained in nonvolatile residues test, add sulfuric acid 
and burn on the muffle furnace until constant weight. Treat the blank reagent similarly. The 
difference between the two volumes should not be greater than 5.0 mg. It is not necessary to 
perform this test when the nonvolatile residue test result does not exceed 5.0 mg.  
Heavy Metal, as lead: an aliquot of extraction solution has been transferred to a volumetric 
flask and acidified with nitric acid and the volume was completed with the extraction 
solution. After treating the sample, the lead content was quantified by atomic emission 
spectrometry induced by plasma, with an optical detector, in a Perkin Elmer equipment, 
model OPTIMA 2000DV, using appropriate calibration curves for the analyses.  This test 
was conducted in replacement to the heavy metal test stablished by American 
Pharmacopeia, whose result is expressed as lead (and is based on the colour comparison 
among the test solution and a solution of lead with concentration of 1.0 mg / kg). 
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Physicochemical 
Assay 
Limit based on 
USP 
Sample Mean 
Standard 
deviation 
Variation 
interval 
Buffering capacity 
(mL) 
10.0 mL 
Before EtO  0.5(2) (3) (3) 
After EtO  0.5(2) (3) (3) 
Non-volatile residue:
(mg) 
15 mg 
Before EtO  1.0(2) (3) (3) 
After EtO  1.0(2) (3) (3) 
Heavy Metals (as 
lead) 
(mg/kg (ppm)) 
1 mg/kg 
(ppm) 
Before EtO  0.05(2) (3) (3) 
After EtO  0.05(2) (3) (3) 
(1) Results of three determinations. 
(2) Corresponds to the limit of quantification of the method in the analytical conditions used. 
(3) Values no applicable 
Table 8. Physicochemical assays of the analyzed samples(1). 
E 2.) Assays According to the European Pharmacopoeia 
The tests acidity or alkalinity, sulfated ash, absorbance, extractable aluminum, chromium, 
titanium, vanadium, zinc, zirconium and extractables from heavy metals, expressed as 
lead were conducted based in the methodology described in the European 
Pharmacopoeia, Chapters “3.1.3 Polyolefines”, “3.1.4 Polyethylene without Additives for 
Containers for Parenteral Preparations and for Ophthalmic Preparations” and “3.1.5 
Polyethylene with Additives for Containers for Parenteral Preparations and for 
Ophthalmic Preparations”. 
Extractables of aluminium, chromium, titanium, vanadium, zinc and zirconium 
The methodology for quantification of extractables aluminum, chromium, titanium, 
vanadium, zinc and zirconium involved contact of 100 grams of sample with a solution of 
0.1 M hydrochloric acid for one hour at the reflux temperature. After treating the sample, 
the metals contents were quantified by atomic emission spectrometry induced by plasma, 
with an optical detector, in a Perkin Elmer equipment, model OPTIMA 2000DV, using 
appropriate calibration curves for the analyses.   
Extractables of Heavy Metals, expressed as lead 
The same procedure described for quantification of extractable aluminum, chromium, 
titanium, vanadium, zinc and zirconium was used. The method for quantification of 
extractable lead was used instead of the colorimetric method of determination of heavy 
metals established by the European Pharmacopoeia, which is based on color comparison 
between the extracting solution and a solution of lead at a concentration of 2.5 mg/kg. 
Alkalinity or Acidity, and Absorbance 
The method for quantification of alkalinity or acidity and absorbance involved contact of 
12.5 grams of sample with 250 mL of deionized water for five hours at the reflux 
temperature. 
After the extraction time, both the extracting solution in contact with the samples and a 
blank solution (reference) were assessed as to the following tests:  
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Alkalinity and Acidity: measurement of pH in a Micronal pHmeter, model B 474 and 
titration of 100 mL of extracting solution with sodium hydroxide 0.01M or hydrochloric acid 
0.01M up to pH 7.0.  
Absorbance: absorbance of the extracting solution was measured in the 220 nm to 340 nm 
wavelength range, using a quartz cuvette with 10 mm pathlenght in a UV / VIS 
spectrophotometer, using an Analytik Jena instrument, model Specord 210. 
Sulphated Ash 
Sulfated ash were assessed per requirements in European Pharmacopoeia 6.0, Chapter 2.4.14 
- Sulfated Ash. The method for quantification of sulfated ash consisted in weighing 5.00 g  
0.01 g of sample on an analytical scale with 10-5 g resolution and incineration at a 
temperature of  600 °C  20 ºC using a Milestone microwave heating furnace, model Pyro. 
After incinerating the sample, the ash were determined gravimetrically, using an analytical 
scale with 10-5 g resolution. There was not need to use sulfuric acid. 
Extractable aluminum, chromium, titanium, vanadium, zinc and zirconium 
The results of the extractable aluminum, chromium, titanium, vanadium, zinc and 
zirconium tests for the analyzed sample are shown in Table 9. 
 
Extractables 
Limit based on 
European 
Pharmacopeia 6.0 
Sample Mean 
Standard 
Deviation 
Variation 
interval 
Al 1.0 
Before EtO 0.71 0.08 0.62 – 0.78 
After EtO 0.74 0.06 0.70 – 0.81 
Cr 0.05 
Before EtO 0.03 0.00 0.02 – 0.03 
After EtO 0.33 0.05 0.27 – 0.37 
Ti 1.0 
Before EtO  0.10(2) (3) (3) 
After EtO  0.10(2) (3) (3) 
V 0.10 
Before EtO  0.10(2) (3) (3) 
After EtO  0.10(2) (3) (3) 
Zn 1.0 
Before EtO 0.05 0.00 0.05 – 0.06 
After EtO 0.05 0.01 0.05 – 0.06 
Zr 0.10 
Before EtO  0.05(2) (3) (3) 
After EtO  0.05(2) (3) (3) 
(1) Result of four determinations.  
(2) Corresponds to the limit of quantification of the equipment in the analytical conditions used. 
(3) Not applicable. 
Table 9. Extractables of the metals aluminum (Al), chromium (Cr), titanium (Ti), vanadium 
(V), zinc (Zn) and zirconium (Zr), in mg/kg(1). 
Extractable Heavy Metal, Expressed as Lead 
The results of the extractable heavy metals, expressed as lead, acidity, absorbance and 
sulphated ash tests, for the analyzed sample are shown in Table 10. 
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Physicochemical 
Assay 
Limit based on 
European 
Pharmacopeia 6.0
Sample Mean 
Standard 
Deviation 
Variation 
interval 
Extractables of Heavy 
Metals, expressed as 
lead 
(ppm) 
2.5mg/kg (ppm) 
Before EtO  0.1(2) (3) (3) 
After EtO  0.1(2) (3) (3) 
Acidity 
(mL of NaOH 0.01 M)
1.5 mL de sodium 
hydroxide 0.01 M
Before EtO  0.5(2) (3) (3) 
After EtO  0.5(2) (3) (3) 
Absorbance 
(UA) 
0.2 UA 
Before EtO 0.23 0.01 0.22 – 0.23 
After EtO 0.24 0.04 0.22 – 0.26 
Sulphated Ash 
(%) 
0.02% and 1.00%(4)
Before EtO 0.29 0.01 0.28 – 0.30 
After EtO 0.25 0.12 0.11 – 0.33 
UA- Unit of Absorbance. 
(1) Results of three determinations. 
(2) Corresponds to the limit of quantification of the method in the analytical conditions used. 
(3) Values no applicable 
(4) Varies according to the presence of additives 
Table 10. Results for heavy metals, expressed as lead, acidity, absorbance and ash of the 
samples analyzed (1). 
The lead values, volume of 0.1 M sodium hydroxide used, and sulphated ash values found 
in the samples analyzed were below the maximum limits established in the European 
Pharmacopeia 6.0. In relation to absorbance, the values obtained in the two samples 
analyzed, before and after the application of sterilization with ethylene oxide (EtO), were 
slightly higher than the maximum limits established. 
A038-2/11 – Packaging for human tissue – Final Report 17/20 This means that some 
substance of the coextruded film may have migrated to the extraction solution in contact 
with the sample (deionized water), a fact that requires further investigation. 
It should be emphasized that the methodology of the American and European Pharmacopeias 
apply to single-layer packaging, and that substances from internal layers of the film analyzed 
may have been extracted, slightly increasing the absorbance of the extraction solution. 
E 3.) Specific migration 
The extruded film before and after sterilization with ethylene oxide was evaluated in 
relation to specific migration of 1-octene and ε-caprolactam. The evaluations of specific 
migrations of 1-octene, ε-caprolactam and hexamethylenediamine were carried out 
according to the Brazilian legislation. 
E 3.1) Specific migration of 1-octene 
The quantification of specific migration of 1-octene was evaluated based on Standard CEN/ 
TS 13130-26: materials and articles in contact with foodstuffs – Plastics substances subject to 
limitation – Part 26: 
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Determination of 1-octene and tetrahydrofuran in food simulants, and consists of contact of 
the sample with solutions of extraction with times and temperatures that simulate its real 
condition of use. 
The internal sides of the samples were placed in contact with the simulants, obeying an 
area:volume ratio of 600 cm2 to 1000 mL. The same was evaluated in the contact conditions 
shown in Table 11. 
 
Simulants/Contact 
Condition 
Maximum limit of 
specific migration 
of 1-octene 
Sample Mean (1)
Standar
d 
Deviatio
n 
Variation 
Interval 
Ultra purified water/
40oC/10 days 
15 
Before EtO ≤2.8(2) (3) (3) 
After EtO ≤2.8(2) (3) (3) 
3% Acetic acid solution 
in  ultra purified water 
(w/v)/ 
40oC/10 days 
15 
Before EtO 1.6(2) (3) (3) 
After EtO 1.6(2) (3) (3) 
Olive oil/ 
40oC/10 days 
15 
Before EtO 8.7(2) (3) (3) 
After EtO 8.7(2) (3) (3) 
(1) Result of  three determinations. 
(2) Quantification Limit of the method under the analytical conditions. 
(3) Not applicable. 
Table 11. Specific migration of 1-octene obtained for transparent coextruded plastic film, 
before and after the application of EtO, in mg/dm2. 
The specific limit of monomer migration of 1-octene established in Resolution 105/99 of the 
National 
Health Surveillance Agency – ANVISA of 19 May 1999 is 15 mg/kg of simulant. The values 
for specific migration of 1-octene found in the samples analyzed, in the analytical conditions 
used, were below the established limit. Sterilization with ethylene oxide (EtO) did not affect 
the monomer migration potential of 1-octene. 
E 3.2) Specific migration of ε-caprolactam 
The quantification of specific ε-caprolactam was evaluated based on Standard CEN/ TS 
13130-16: materials and articles in contact with foodstuffs – Plastics substances subject to 
limitation - Part 16: Determination of caprolactam and caprolactam salt in food simulants. 
The internal surfaces of the samples were placed in contact with the simulants, obeying an 
area:volume ratio of 600 cm2/1000 mL. The samples were evaluated under the contact 
conditions shown in Table 12. 
The specific limit of monomer migration of ε-caprolactam established in Resolution 105/99 
of the National Health Surveillance Agency – ANVISA of 19 May 1999 is 15 mg/kg of 
simulant. The values for specific migration of ε-caprolactam found in the samples analyzed, 
in the analytical conditions used, were below the established limit. Sterilization with 
ethylene oxide (EtO) did not affect the potential monomer migration of ε-caprolactam for 
the fatty simulant, but was significantly lower (probability of 95% confidence – Tukey Test) 
www.intechopen.com
 
Validation of Primary Packaging for Cryopreserved Musculoskeletal Tissues 83 
for the ultrapure water simulants and 3% acetic acid solution (m/v) in ultrapure water after 
sterilization with ethylene oxide. 
 
Simulants/Contact 
Condition 
Maximum limit of 
specific migration of 
-caprolactam 
Sample Mean (1) 
Standard 
Deviation 
Variation 
Interval 
Ultra purified water/
40oC/10 days 
15 
Before EtO 2.4 0.3 1.9 - 2.7 
After EtO 1.7 0.2 1.3 - 1.9 
3% Acetic acid solution 
in  ultra purified water 
(w/v)/ 
40oC/10 days 
15 
Before EtO 2.7 0.1 2.6 - 2.8 
After EtO 2.2 0.3 1.8 - 2.6 
Olive oil/ 
40oC/10 days 
15 
Before EtO 3.4 0.4 3.0 - 4.0 
After EtO 3.2 0.2 2.9 - 3.5 
(1) Result of  three determinations. 
Table 12. Specific migration of -caprolactam obtained for transparent coextruded plastic 
film, before and after the application of EtO, in mg/dm2. 
E 3.3) Specific migration of hexamethylenediamine 
The quantification of specific hexamethylenediamine migration was evaluated based on 
Standard CEN/ TS 13130-21: materials and articles in contact with foodstuffs - Plastics 
substances subject to limitation – Part 21: Determination of ethylenediamine and 
hexamethylenediamine in food simulants. The sample of hexamethylenediamine, adipic 
acid e caprolactam copolyamide in the form of a film, was placed in contact with the 
simulants, obeying an area:volume ratio of 600 cm2  to 1000 mL. The sample was evaluated 
under the contact conditions shown in Table 13. 
 
Simulants/Contact Condition 
Maximum limit of specific 
migration of 
hexamethylenediamine 
Mean (1) 
Standard 
Deviation 
Variation 
Interval 
Ultra purified water/
100 ºC/30 minutes + 40 oC/10 
days 
2,4 1.2(2) (3) (3) 
3% Acetic acid solution  in  ultra 
purified water (w/v)/ 
100 ºC/30 minutes + 40 oC/10 
days
2,4 1.1(2) (3) (3) 
Olive oil/
100 ºC/30 minutes + 40 oC/10 
days
2,4 2.0(2) (3) (3) 
(1) Result of three determinations. 
(2) Quantification Limit of the method under the analytical conditions. 
(3) Not applicable. 
Table 13. Specific migration of hexamethylenediamine obtained for a 42 m film 
copolyamide, in mg/kg. 
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The specific limit of monomer migration of hexamethylenediamine established in 
Resolution 105/99 of the National Health Surveillance Agency – ANVISA of 19 May 1999 is 
2.4 mg/kg of simulant. The values for specific migration of hexamethylenediamine found in 
the analysis of the 42 µm film copolyamide, under the analytical conditions used, were 
below the established limit. 
3.3 Cytotoxicity assay  
Assay performed in accordance with Standard ISO 10993-5: Biological evaluation of 
medical devices – Part 5: Cytotoxicity Assays: in vitro methods in samples of coextruded 
plastic film. 
3.3.1 Cytotoxicity 
Definitions of cytotoxicity vary, depending on the nature of the study and whether cells are 
killed or simply have their metabolism altered. Cytotoxicity is the toxicological effect that a 
substance can cause in vitro, at cellular level (Freshney, 2000). 
As defined in ISO 10993, “the numerous methods used and end-points measured in 
cytotoxicity determination can be grouped into categories of evaluation type, like 
assessments of cell damage by morphological means; measurements of cell damage; 
measurements of cell growth and measurements of specific aspects of cellular metabolism” 
[IOS, 2010]. The cells can be exposed to the samples or their extracts. 
3.3.2 The protocols 
Cell culture 
Chinese hamster ovary cell line (CHO-k1) was standardized for cytotoxicity and 
genotoxicity tests. Cells were maintained in RPMI medium supplemented with antibiotics 
and antimycotics (100 units/mL penicillin, 100 µg/mL streptomycin and 0.025 µg/mL 
amphotericin), 2mM glutamine, and 10% calf serum, at 37o C in a humidified 5% CO2 
atmosphere until they reached confluence. For subculturing and for experiments, cells were 
harvested using 0.05% trypsin and 0.02% EDTA in phosphate-buffered saline, pH 7.4. 
Extract preparation 
Samples of packaging, before and after sterilization, were submitted to this assay. The 
samples were immersed separately in RPMI culture medium at a final concentration of 1 
cm2 / mL and left in an incubator at 37oC for 72 hours to fulfil the extraction condition. The 
first concentration was sterilized by filtration and the subsequent dilutions were performed 
in sterile RPMI medium at a ratio of 1:2. 
Cytotoxicity test 
A colorimetric method that uses the tetrazolium compound MTS was used to determine the 
number of viable cells in proliferation (Cory et al, 1991). 96-well microplates were prepared 
with 50 µL of extract diluted from 100 to 6.25% in RPMI medium in quadruplicates. The 
positive control was a phenol solution (0.5% v/v) as 100% concentration and the negative 
control was a high density polyethylene (HDPE) extract. The 100% concentration was the 
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non-extract well A suspension of CHO-k1 (from second to fourth passages after thawing) 
with 6 x 104 cell/mL was prepared and 50 µL/well was pipetted into the microplates. The 
microplates were incubated for 72 hours at 37oC in a humidified 5% CO2 atmosphere. Blank 
and controls of the cells were also prepared. Cell viability was measured by adding 20 µL of 
MTS/PMS (20:1) solution to the humidified 5% CO2 incubator, followed by incubation for 2 
hours at 37oC. The microplates were read in a spectrophotometer reader at 490 nm.  
Cell viability was calculated by the equation: 
ODsample
CV%= ×100
ODnonextract
 
Where: CV% = cell viability, OD sample = optical density at 490 nm of the extract dilution, 
OD non extract = optical density at 490 nm of the well without extract. 
The results consider the following parameters: 
a. Controls (positive and negative) 
Positive control: 0.5% Phenol solution  
Negative control: HDPE (high-density polyethylene) extract. 
b. Observations: definitions of some terms. 
 Positive control: material which, when tested according to Standard ISO 10993-5, 
promotes a cytotoxic response. 
 Negative control: material which, when tested according to Standard ISO 10993-5, 
does not promote a cytotoxic response. 
 IC50(%): cytotoxicity index 50%, concentration of extract that kills 50% of the viable 
cell population. 
The results of the assay showed that the samples of packaging material, before and after 
sterilization by ethylene oxide (EtO), resulted in viability of over 90%, and therefore do not 
become cytotoxic. 
3.4 Sterility assay and ethylene oxide residues 
The samples were classified according to their position (0 to 5a; 0 to 5b) during exposure to 
EtO, for the penetration analysis. The outermost or surface position corresponds to the 
number 5, and the innermost position to the number 0. (Figure 6) 
Sterility tests were carried out through the analyses of two biological indicators (bi 3M - 
ATTEST –TM Bacillus atrophaeus and Terragene – Bionova BT40 - Bacillus atrophaeus). 
Incubation time was 48 h at a temperature of 35°C ± 1.5.  
Samples of packaging were also submitted to direct incubation for 7 days with TSB liquid 
culture at a temperature of 35°C ± 1.5. The methodology used is in accordance with the 
Brazilian Pharmacopoeia. The analyses of the three sterility tests (biological indicator 
Bionova BT40, 3Mattest and direct incubation) confirm the sterility of the packaging 
material after being submitted to ethylene oxide gas. 
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Fig. 6. Samples of packaging positioned from 0 to 5 for EtO penetration analysis.  
 
Fig. 7 and 8. Performance of the sterility test by direct incubation in samples submitted to 
ethylene oxide. 
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The analysis of ethylene oxide residues was performed by the Gas Chromatography test, 
determining the levels of Ethylene chlorohydrin and Ethylene glycol. The data are shown in 
Figure 9 and show that the levels are within the limits accepted by our legislation. 
 
 
 
 
 
Note. Maximum limits according to the Brazilian legislation. [ ETO up to 25/ ETCH up to 25/ETG up to 
250] 
Fig. 9. Residues (ETO, ETCH, ETG) found in the samples submitted to sterilization. 
4. Final considerations 
Analyses of the packaging used in this study demonstrated that it is a good option for 
cryopreservation of tissues at a temperature of – 80ºC.  
Our experience with assays to validate coextruded polyethylene and polyamide plastic film 
shows that the mechanical properties of this material are not altered by cryopreservation 
and sterilization. Penetration resistance of the thermal seal remained unaltered after all the 
processes carried out in a tissue bank, such as sterilization and cryopreservation. 
We found a loss of barrier due to increased oxygen permeability of around 10% after 
sterilization and cryopreservation, which can be explained by the humidification of the 
polyamide. However, this slight alteration in oxygen permeability does not compromise the 
inner vacuum of the packaging, and does not place at risk the tissue packaged in it. 
In relation to total migration, we did not observe any alterations in the assays, i.e. once 
again, sterilization and cryopreservation did not lead to monomer migration at levels above 
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those required by our legislation. This is also valid for specific migrations of 1-octene, ε-
caprolactam and hexamethylenediamine. 
The application of ethylene oxide is safe for sterilization of this type of packaging, as it results 
in good penetrability and safe levels of Eto, Etch and Etg residues at the end of the procedure. 
In the cytotoxicity test, we observed levels of cell viability of over 90%, therefore they do not 
become cytotoxic. 
Thus, analyses of coextruded plastic polyethylene and polyamide film used in this study 
proved to be a good option for cryopreservation of tissues at temperatures of –80ºC, even for 
prolonged periods of 150 days. 
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